Cold Sores Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial
This study is the first to assess the efficacy of FIT039 and will contribute to the development of antiviral agents that can cure refractory common warts in immunocompromised patients.Trial registrationUMIN Clinical Trials,UMIN000029695. Registered on 1 November 2017. (Source: Trials)
Source: Trials - August 8, 2019 Category: Research Source Type: clinical trials

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
Condition:   Recurrent Herpes Labialis Interventions:   Drug: BOR15001L7;   Drug: Docosanol Cream 10% Sponsors:   Laboratoire Boreaderme Inc.;   Ecogene 21 Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2019 Category: Research Source Type: clinical trials